Germany 2003: Schmidt sets out on the rocky road to reform
This article was originally published in Clinica
Executive Summary
It was a turbulent year for the German health service, with health minister Ulla Schmidt following in the footsteps of Martin Luther and Count Otto von Bismark on the path of reform. But far from nailing her own 95 proclamations to the church door or uniting all parties under her command, Ms Schmidt, from the ruling Socialist and Green Party coalition, was forced to go cap in hand to the opposition and reach a consensus agreement on the most wide-ranging health reform in recent years. Faraz Kermani reports
You may also be interested in...
Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking
Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.
Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use
The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip